Answer
Female patients of childbearing potential should use effective contraception throughout faricimab (Vabysmo) treatment and for at least 3 months after the last intravitreal injection.
Sources for this answer
- Vabysmo 120 mg/mL solution for injectionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked